eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs).

Biotechnology

eFFECTOR Therapeutics

Steve Worland

Mark Densel

Gary Chiang

Sam Sperry

Doug Warner

Mike Byrnes

The executive team at eFFECTOR Therapeutics has experience in finance and accounting from companies in the biopharmaceutical industry. This experience includes working as a Sr. Vice President, Chief Financial Officer, Corporate Controller, and at various other finance-related positions. The team members also have education in finance from Santa Clara University and California State University - East Bay.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at eFFECTOR Therapeutics

Board of Directors

Leadership Team